SOBI.XSTO Overview
Upcoming Projects (SOBI.XSTO)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (SOBI.XSTO)
-
Investigating the recent FDA approval of Gamifant (emapalumab-lzsg), the first treatment for Macrophage Activation Syndrome in Still's disease
Ticker: SOBI.XSTO
Executed On: Sep 18, 2025 at 05:00 PM EDT -
Analyzing the Phase 3 VALIANT Study Results for Pegcetacoplan in C3G and IC-MPGN from Apellis and Sobi
Tickers: APLS, SOBI.XSTO
Executed On: Sep 05, 2024 at 02:00 PM EDT
Upcoming & Overdue Catalysts (SOBI.XSTO)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (SOBI.XSTO)
-
Apellis (APLS) and Sobi Announce EU Approval of Aspaveli (pegcetacoplan) for Treatment of PNH
Tickers: APLS, SOBI.XSTO
Occurred on: Dec 15, 2021
Strategic Initiatives (SOBI.XSTO)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
